Featured

The Importance of Utilizing Registered Dietitians and Multidisciplinary Care for Patients Prescribed Anti-Obesity Medications

Integrating a multi-disciplinary Care Team into a comprehensive, patient-centered care model can enhance treatment efficacy and address challenges like nutritional needs and side effects.

Published:

August 14, 2024

Written by:

Sheena Batura, MS, RDN, CSOWM, LD

Registered Dietitian

Medically Reviewed by:

Published:

August 16, 2024

From Our Care Team
From Our Care Team
From Our Dietitians
From Our Dietitians
Our Care
Our Care

Anti-Obesity Medications (AOMs) have surged in use and interest in how best to support patients taking these medications has rightfully received heightened attention. AOMs, especially the newest generation of GLP-1 RAs, have demonstrated powerful weight loss outcomes resulting in anywhere from 10-20%1,2 excess weight loss, when even 5-10% is clinically meaningful.3 

While we continue to develop best practices for treating patients with obesity, including the use of AOMs as part of treatment, prescribing physicians need to lean on a multidisciplinary care team for robust care, which includes a registered dietitian. 

At Salvo Health, we’re focused on supporting existing physician-led practices by equipping providers with a multidisciplinary team to deliver best-in-class, whole person centered care. Physicians continue to lead the plan of care to help patients with obesity meet their health goals, while the team at Salvo ensures patients remain engaged and supported.  

A multidisciplinary approach isn’t a new concept for many patients with chronic conditions, and in the weight management realm, specifically bariatric surgery, it has been a longstanding standard of care. Utilizing the expertise of a multidisciplinary team, including a registered dietitian, licensed therapist, exercise physiologist, and more, has resulted in better patient outcomes, reduced risk for complications, and led to better patient quality of life.4  We know that post-bariatric surgery patients have very unique nutritional needs, are are at a heightened risk for micronutrient deficiencies. Many patients experience tolerance issues with certain foods, and need long term support when navigating the changes they experience after surgery.

While AOMs effectively blunt appetite and thereby decrease total caloric intake, nutritional counseling delivered by a registered dietitian is still a paramount aspect of treatment. Registered dietitians are uniquely poised to best support these patients’ specific needs due to their specialized knowledge in nutrition and ability to garner better outcomes.5-7 At Salvo Health, we ensure patients receive a comprehensive evaluation by a registered dietitian which is used to develop an incredibly personalized plan. We harness technology when delivering care through an interactive app that helps patients remain connected and on track.

Patients who are connected with their care team can be better supported and empowered. There are also inherent risks for each intervention, including treatment that includes the use of AOMs or surgery. Registered dietitians can effectively optimize nutritional intake to stave off the potential for malnutrition, or micronutrient deficiencies.8 RDs can provide individually tailored recommendations in order to support the preservation of lean muscle mass,9 which is an area of concern during rapid weight loss. Many patients taking AOMs are experiencing gastrointestinal side effects10-11 such as nausea, diarrhea and constipation, which requires additional attention and support to prevent nutrient-poor food choices and reduce the risk of dropout during treatment. Salvo Health’s Remote Patient Monitoring (RPM) program considers the potential for these nutritional risks, and ensures patients receive proactive support in order to meet nutritional needs or to circumvent GI side effects.

We also know that supply, accessibility and coverage for AOMs remain challenging for patients. Many patients are experiencing discontinuation of use or a pause for these reasons, which causes frustration and anxiety due to fear of weight regain. During lapses in treatment, it’s important for patients to continue receiving nutritional counseling led by a registered dietitian to ensure patients remain focused on establishing long-term lifestyle change and mitigate the potential for weight regain.7 During lapses in medication use, it’s key to ensure patients continue to have a source of accountability and support, as well as contingency strategies rooted in behavior change. The core of what we do at Salvo Health is to support patients with making small changes that lead to larger behavioral change. During lapses in treatment, we encourage patients to continue to keep up the momentum of change by helping them with continuing to build on their existing goals.  

Ultimately, weight management is a team approach and it’s essential to lean on a qualified and trusted multidisciplinary team to deliver improved patient outcomes and quality of life.

Share this article

Written by:

Sheena Batura, MS, RDN, CSOWM, LD

Registered Dietitian

References:

  1. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183
  2. Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. doi:10.1056/NEJMoa2206038
  3. Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society [published correction appears in Circulation. 2014 Jun 24;129(25 Suppl 2):S139-40]. Circulation. 2014;129(25 Suppl 2):S102-S138. doi:10.1161/01.cir.0000437739.71477.ee
  4. Marshall S, Mackay H, Matthews C, Maimone IR, Isenring E. Does intensive multidisciplinary intervention for adults who elect bariatric surgery improve post-operative weight loss, co-morbidities, and quality of life? A systematic review and meta-analysis. Obes Rev. 2020;21(7):e13012. https://doi.org/10.1111/obr.13012.
  5. Raynor HA, Morgan-Bathke M, Baxter SD, et al. Position of the Academy of Nutrition and Dietetics: Medical Nutrition Therapy Behavioral Interventions Provided by Dietitians for Adults With Overweight or Obesity, 2024. J Acad Nutr Diet. 2024;124(3):408-415. doi:10.1016/j.jand.2023.11.013
  6. Report: The Evolving Role of Registered Dietitian Nutritionists in Obesity Management with Medications and Lifestyle Interventions. The Academy of Nutrition and Dietetics. Published June 20, 2024.
  7. Morgan-Bathke M, Baxter SD, Halliday TM, et al. Weight Management Interventions Provided by a Dietitian for Adults with Overweight or Obesity: An Evidence Analysis Center Systematic Review and Meta-Analysis. J Acad Nutr Diet. 2023;123(11):1621- 1661.e1625.
  8. Almandoz JP, Wadden TA, Tewksbury C, et al. Nutritional considerations with antiobesity medications. Obesity (Silver Spring). Published online June 10, 2024. doi:10.1002/oby.24067
  9. Neeland IJ, Linge J, Birkenfeld AL. Changes in lean body mass with glucagon-like peptide-1-based therapies and mitigation strategies. Diabetes Obes Metab. Published online June 27, 2024. doi:10.1111/dom.15728
  10. Aldhaleei WA, Abegaz TM, Bhagavathula AS. Glucagon-like Peptide-1 Receptor Agonists Associated Gastrointestinal Adverse Events: A Cross-Sectional Analysis of the National Institutes of Health All of Us Cohort. Pharmaceuticals (Basel). 2024;17(2):199. Published 2024 Feb 2. doi:10.3390/ph17020199
  11. Gorgojo-Martínez JJ, Mezquita-Raya P, Carretero-Gómez J, et al. Clinical Recommendations to Manage Gastrointestinal Adverse Events in Patients Treated with Glp-1 Receptor Agonists: A Multidisciplinary Expert Consensus. J Clin Med. 2022;12(1):145. Published 2022 Dec 24. doi:10.3390/jcm12010145